罗斯科维丁通过抑制CDK5-介导的Tau高酸化来缓解类似PTSD的认知障碍
Baowen Dong1, Mengmeng Chang1, Kailu Li2
1College of Life Science, Northwest University, Xi'an 710069, China; Medical Innovation Center, Fourth Military Medical University, Xi'an 710032, China.
Brain research bulletin
|October 19, 2025
概括
创伤后应激障碍 (PTSD) 涉及海马体损伤. 早期用Roscovitine向CDK5,可以减少Tau酸化,保护神经元,并减轻PTSD行为.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 认知障碍 认知障碍 认知障碍
背景情况:
- 创伤后应激障碍 (PTSD) 是一种与创伤相关的认知障碍,有效治疗方法有限.
- 海马体损伤与PTSD的发展有关,但机制尚不清楚.
- 了解PTSD的分子基础对于开发新疗法至关重要.
研究的目的:
- 调查循环林依赖激酶5 (CDK5) 和陶蛋白酸化在PTSD中的作用.
- 在PTSD小鼠模型中评估Roscovitine (Rosc) 的治疗潜力.
主要方法:
- 一个经过修改的单一长期压力和电脚冲击 (SPS&S) 模型在小鼠中诱导了类似PTSD的行为.
- 在压力后分析了海马的酸化和CDK5活性.
- 小鼠接受了早期的Rosc治疗,以评估其对神经发生,神经元结构和行为的影响.
主要成果:
- 在海马体中,SPS&S诱导了CDK5依赖的Tau过酸化 (AT8位点).
- 罗斯克治疗抑制了CDK5,减少了Tau酸化,并保留了神经发生.
- 罗斯克恢复了树突复杂性,并减轻了小鼠的焦虑和恐惧记忆行为.
结论:
- 海马体中CDK5-介导的Tau过酸化是PTSD的一个关键病理过程.
- 早期的Rosc干预表明,通过准CDK5.5,对PTSD治疗有希望.
- 这项研究突出了与PTSD相关的认知障碍的潜在治疗策略.
相关概念视频
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Post-traumatic Stress Disorder
475
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
475
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


